A 35 Day Study to Investigate the Effects of GSK1521498 on Bodyweight in Obese Subjects With Over-Eating Behaviours.
Clinical trial NCT01195792 · COMPLETED
Trial details
- NCT number
- NCT01195792
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2011-05-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.